$1.37B
$153,000
0.0% of portfolio
9,348
Q2 2024
Added 8.7%
$246M
$77,000
0.0% of portfolio
9,500
Q2 2024
Added 2.87%
$44.5M
$0
0.0% of portfolio
59
Q2 2024
New
Inovio Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 53.28%
$232M
$11 Million
0.0% of portfolio
2,477,427
Q2 2024
Added 25.92%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.99%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.4%
$3.51B
$33.2 Million
0.0% of portfolio
364,357
Q2 2024
Reduced 28.47%
$260M
$4,000
0.0% of portfolio
455
Q2 2024
Added 2.48%
$644M
$20,000
0.0% of portfolio
675
Q2 2024
Reduced 11.42%
$3.34B
$20,000
0.0% of portfolio
882
Q2 2024
Added 1.15%
-
$0
0.0% of portfolio
-
Q2 2024
Added 215.56%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 48.09%
$1.46B
$6.25 Million
0.0% of portfolio
214,410
Q2 2024
Added 343.55%
$1.75B
$44,000
0.0% of portfolio
4,603
Q2 2024
Added 16.18%
$1.74B
$49.9 Million
0.0% of portfolio
2,228,418
Q2 2024
Added 1.0%
$40.1M
$0
0.0% of portfolio
150
Q2 2024
New
$2.12B
$0
0.0% of portfolio
1
Q2 2024
New
$3.8B
$344,000
0.0% of portfolio
2,970
Q2 2024
Added 15.21%
$2.88B
$59 Million
0.0% of portfolio
2,633,838
Q2 2024
Reduced 0.38%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 7.34%
$4.09B
$306,000
0.0% of portfolio
2,626
Q2 2024
Added 16.25%
$1.12B
$585,000
0.0% of portfolio
39,870
Q2 2024
Added 10.23%
$3.97B
$15.6 Million
0.0% of portfolio
272,292
Q2 2024
Added 5.43%
$4.44B
$52.3 Million
0.0% of portfolio
2,554,485
Q2 2024
Added 56.46%
$724M
$133,000
0.0% of portfolio
6,400
Q2 2024
Added 397.28%
$2.54B
$11.1 Million
0.0% of portfolio
187,603
Q2 2024
Reduced 0.87%
$78.4M
$3,000
0.0% of portfolio
404
Q2 2024
Reduced 34.42%
$84.8M
$6,000
0.0% of portfolio
1,780
Q2 2024
Reduced 31.14%
$333M
$24,000
0.0% of portfolio
1,029
Q2 2024
Added 4.26%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.71%
$30M
$0
0.0% of portfolio
120
Q2 2024
Reduced 40.0%
$2.01B
$63,000
0.0% of portfolio
2,574
Q2 2024
Added 11.77%
$0
$38.9 Million
0.0% of portfolio
2,769,471
Q2 2024
Added 3.41%
$109M
$15,000
0.0% of portfolio
128
Q4 2023
Reduced 36.95%
$232M
$13,000
0.0% of portfolio
136
Q1 2024
Added 195.65%
$136M
$11,000
0.0% of portfolio
200
Q2 2024
New
$262M
$0
0.0% of portfolio
4
Q2 2024
Reduced 77.78%
$3.5B
$1,000
0.0% of portfolio
74
Q2 2024
Added 3,600.0%
$2.3B
$2,000
0.0% of portfolio
125
Q2 2024
Added 23.76%
$0
$85,000
0.0% of portfolio
1,593
Q2 2024
Added 61.07%
$0
$316,000
0.0% of portfolio
3,719
Q2 2024
Added 5.29%
$0
$9,000
0.0% of portfolio
491
Q2 2024
Added 21.23%
$0
$0
0.0% of portfolio
57
Q2 2024
Added 5,600.0%
$0
$911,000
0.0% of portfolio
18,715
Q2 2024
Added 48.93%
$0
$2,000
0.0% of portfolio
56
Q1 2024
New
$0
$25,000
0.0% of portfolio
844
Q2 2023
New
$0
$369,000
0.0% of portfolio
3,985
Q2 2024
Added 21.87%
$0
$190,000
0.0% of portfolio
3,443
Q2 2024
Added 40.24%